The liver, responsible for drug metabolism in the body, is also most at risk of damage due to medicines. Unravel the complexities of DILI and its impact on medication safety.


When it comes to our health, the liver plays a crucial role in processing and detoxifying substances, including medications. However, it can also be badly damaged by medicines and their compounds, resulting in drug-induced liver injury (DILI). In the latest episode of Drug Safety Matters, Rita Baião from the North Lisbon University Hospital Center discusses the complexities of DILI, who is most at risk of developing it, and the proactive measures taken during drug development to mitigate damage.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

You may also like


A Life Dedicated to Drug Safety

Prof. Singhal passed away on 19 April 2025. He is survived by his wife, children, and a large community of pharmacology researchers who had the privilege of training under him.

02 July 2025

Winning the war against health mis and disinformation

Public health is at risk now more than ever; with AI it has never been easier to spread mis- and disinformation on health. How do we work smarter to address this threat?

17 June 2025

Ronald Meyboom: A professional life devoted to pharmacovigilance

Ronald Meyboom, pioneering pharmacovigilance expert who helped establish drug safety monitoring in the Netherlands, died 27 April. He was 79.

11 June 2025